Key result
Oral disopyramide has earned a recognized role in treating ventricular arrhythmias, with six years of clinical experience refining dosing guidelines and patient selection.
Oral disopyramide has an established role in treating ventricular arrhythmias, with refined dosing and patient selection based on six years of clinical experience.
Answers are grounded in this paper and cite their sources.
May inform dosing and selection for ventricular arrhythmias; extends historical data but leaves open modern randomized validation.
Since its approval by the FDA six years ago, oral disopyramide has earned a recognized role in the treatment of ventricular arrhythmias. During this time, clinical experience has refined our knowledge of this agent, allowing revision of dosing guidelines and better selection of patients. This review explores the recent therapeutic experience with disopyramide.
No takes yet. Share an insight, caveat, or question.
Andrew G. Wallace (1983) studied this question. Oral disopyramide has earned a recognized role in treating ventricular arrhythmias, with six years of clinical experience refining dosing guidelines and patient selection.
Synapse has enriched 10 related papers. Consider them for comparative context: